Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2018 Nov/Dec;93(6):843-851.
doi: 10.1590/abd1806-4841.20187589.

Evaluation of skin expression profiles of patients with vitiligo treated with narrow-band UVB therapy by targeted RNA-seq

Affiliations
Comparative Study

Evaluation of skin expression profiles of patients with vitiligo treated with narrow-band UVB therapy by targeted RNA-seq

Jorge Ocampo-Candiani et al. An Bras Dermatol. 2018 Nov/Dec.

Abstract

Background: Vitiligo is characterized by a lack of pigmentation in the skin. To date, there are no studies that analyze the changes in gene expression in the skin of vitiligo patients in response to narrow-band ultraviolet B (nb-UVB) phototherapy treatment.

Objective: Explore the usefulness of new generation RNA sequencing in the identification of gene expression changes in the skin of vitiligo patients treated with nb-UVB phototherapy.

Methods: Four skin biopsies (4mm in diameter) were collected from 45 Mexican vitiligo vulgaris patients, 2 specimens before and 2 after treatment with nb-UVB phototherapy, obtained from pigmented and non-pigmented tissue. RNA extracted from the biopsies was analyzed using the Illumina TruSeq Targeted RNA Expression protocol to study the expression of genes that participate in pathways of skin homeostasis. The 2 groups were compared using Student's t-test and the Mann-Whitney U-test.

Results: The expression analysis identified differences in 12 genes included in this study after comparing the samples obtained before and after treatment: 5 genes involved in skin pigmentation, 2 genes involved in apoptosis, 2 genes involved in cell survival, 2 genes involved in oxidative stress responses and 1 gene involved in signal transduction mechanisms (p<0.05).

Study limitations: The small size of skin biopsies limits the amount of RNA obtained, the number of genes to be analyzed and the use of conventional techniques such as RT-qPCR.

Conclusion: We demonstrated usefulness of new generation RNA sequencing in the identification of gene expression changes, in addition to identifying new targets in the study of vitiligo.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: None.

Figures

Figure 1
Figure 1
Heat map of expression patterns from biopsies obtained before and after treatment. In the figure, the vertical axis represents the gene expression patterns of the samples obtained for each gene (horizontal). Sample color codes indicate tissue with vitiligo (blue), unaffected skin (black) before treatment, repigmented skin (green) and vitiligo that did not repigment (red) after nb-UVB treatment. The red coloration within the heat map corresponds to over expression, while white corresponds to intermediate expression, and blue corresponds to sub expression
Figure 2
Figure 2
Heat map of expression patterns grouped according to vitiligo type and disease improvement. At the top of the heat map, the following study groups are represented: type and subtype of sample according to pigmentation (black and red), and improvement (black corresponding to less than 10% improvement, red corresponding to 10%-30% improvement and green corresponding to more than 30% improvement). The vertical axis represents the expression patterns of the samples obtained for each of the genes (horizontal). The red color within the heatmap corresponds to over expression, while white corresponds to intermediate expression, and blue corresponds to sub expression

Similar articles

Cited by

References

    1. Sehgal VN, Srivastava G. Vitiligo: compendium of clinico-epidemiological features. Indian J Dermatol Venereol Leprol. 2007;73:149–156. - PubMed
    1. Steiner D, Bedin V, Brito MB, Tadeu RT, Steiner T. Vitiligo. An Bras Dermatol. 2004;79:335–351.
    1. Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58–58. - PMC - PubMed
    1. Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. J Dermatol Sci. 2006;41:3–10. - PubMed
    1. Spritz RA. The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res. 2007;20:271–278. - PubMed

Publication types